Headlines
Google develops AI co-scientist to aid researchers
Published by Global Banking & Finance Review®
Posted on February 19, 2025
2 min readLast updated: January 26, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on February 19, 2025
2 min readLast updated: January 26, 2026
Google's AI co-scientist aids biomedical research by synthesizing literature and generating hypotheses, showing promising results in liver fibrosis studies.
By Muvija M
LONDON (Reuters) - Google has developed an AI tool to act as a virtual collaborator for biomedical scientists, the U.S. blue chip said on Wednesday.
The new tool, tested by scientists at Stanford University in the U.S. and Imperial College London, uses advanced reasoning to help scientists synthesize vast amounts of literature and generate novel hypotheses, the company said.
AI is being increasingly deployed in the workplace, from answering calls to carrying out legal research, following the success of ChatGPT and similar models over the past year.
Google's AI unit, DeepMind, has made science a priority, and DeepMind boss Demis Hassabis was a co-recipient of a Nobel Prize in Chemistry last year for technology developed in the AI unit.
In an experiment on liver fibrosis, Google said all the approaches suggested by its new AI co-scientist showed promising activity and potential to inhibit causes of disease.
It showed the capacity to improve solutions generated by experts over time, Google added.
"While this is a preliminary finding requiring further validation, it suggests a promising avenue for capable AI systems... to augment and accelerate the work of expert scientists," it said.
The scientists who worked on the project said it would complement rather than replace researchers.
"We expect that it will... increase, rather than decrease scientific collaboration," Google scientist Vivek Natarajan said.
(Reporting by Muvija M; Additional reporting by Kenrick Cai in San Francisco; Editing by Jan Harvey)
Google's new AI tool acts as a virtual collaborator for biomedical scientists, helping them synthesize vast amounts of literature and generate novel hypotheses.
The AI tool was tested by scientists at Stanford University in the U.S. and Imperial College London.
In the liver fibrosis experiment, all approaches suggested by the AI co-scientist showed promising activity and potential to inhibit causes of the disease.
Google believes that the AI tool will complement rather than replace researchers, increasing scientific collaboration.
Demis Hassabis is the head of DeepMind and was a co-recipient of a Nobel Prize in Chemistry last year for technology developed in the AI unit.
Explore more articles in the Headlines category
